PF-06761281

N/A

Report date: 2024/12/03 11:04:12

NME

Base Information

Drug NamePF-06761281

Drug Alias NamePF-06761281

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionNa(+)/citrate cotransporter inhibitors

TargetsNa(+)/citrate cotransporter

Therapy Area/IndicationsMetabolic Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesPfizer Inc

China Registration ClassN/A

Active CompaniesPfizer Inc

Inactive CompaniesN/A

Active IndicationsMetabolic Diseases

Inactive IndicationsN/A

ATC CodeN/A